PMN - ProMIS Neurosciences Inc.
24.05
-0.550 -2.287%
Share volume: 57,166
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$24.60
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-12-2025 | 08-13-2025 | 11-12-2025 | |
| Cash flow financing | 0.000 | 0.000 | 20.945 M | |
| Other financing cash flows | 0.000 | 0.000 | 3.050 K | |
| Cash flow | -4.927 M | 0.000 | 0.000 | |
| Net income | -7.348 M | -10.117 M | -11.580 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | -4.927 M | -3.854 M | 10.889 M |